Search

  • HOME
  • Search
Correspondence
In response to: Steatotic liver disease-know your enemies
Michael H. Le, Linda Henry, Mindie H. Nguyen
Clin Mol Hepatol. 2024;30(2):284-286.   Published online February 19, 2024
View: 573   Download: 15
Original Article
1881
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2024;30(2):235-246.   Published online January 26, 2024
View: 1542   Download: 174  Crossref: 3
Letter to the Editor
Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Kuo Chao Yew, Sunny H. Wong, Vincent Wai-Sun Wong, Hazel H. Oon
Clin Mol Hepatol. 2024;30(1):118-120.   Published online November 14, 2023
View: 1546   Download: 45  Web of Science: 1
Review
1759
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
Clin Mol Hepatol. 2023;29(Suppl):S286-S301.   Published online December 28, 2022
View: 5009   Download: 242  Web of Science: 9  Crossref: 9
1754
Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
Anja Geerts, Sander Lefere
Clin Mol Hepatol. 2023;29(Suppl):S276-S285.   Published online December 22, 2022
View: 3283   Download: 121  Web of Science: 3  Crossref: 4
1749
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg Semmler, Christian Datz, Michael Trauner
Clin Mol Hepatol. 2023;29(Suppl):S244-S260.   Published online December 14, 2022
View: 5089   Download: 289  Web of Science: 6  Crossref: 7
1728
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
Clin Mol Hepatol. 2023;29(Suppl):S157-S170.   Published online November 22, 2022
View: 3533   Download: 294  Web of Science: 12  Crossref: 13
1737
Screening strategy for non-alcoholic fatty liver disease
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(Suppl):S103-S122.   Published online November 30, 2022
View: 4207   Download: 221  Web of Science: 12  Crossref: 14
1740
Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo, Won Kim
Clin Mol Hepatol. 2023;29(Suppl):S68-S78.   Published online December 5, 2022
View: 4404   Download: 284  Web of Science: 16  Crossref: 16
1735
MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
Clin Mol Hepatol. 2023;29(Suppl):S17-S31.   Published online November 29, 2022
View: 10908   Download: 951  Web of Science: 36  Crossref: 47
Letter to the Editor
Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh
Clin Mol Hepatol. 2023;29(4):1046-1047.   Published online August 22, 2023
View: 1309   Download: 35  Web of Science: 1  Crossref: 1
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
Xianhua Mao, Lung Yi Mak, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(3):690-692.   Published online May 30, 2023
View: 1735   Download: 80  Web of Science: 1  Crossref: 1
Original Article
1771
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Clin Mol Hepatol. 2023;29(2):453-464.   Published online February 1, 2023
View: 3189   Download: 114  Web of Science: 2  Crossref: 2
1772
Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi
Clin Mol Hepatol. 2023;29(2):417-432.   Published online November 21, 2022
View: 4593   Download: 164  Web of Science: 2  Crossref: 4
Editorial
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Lynna Alnimer, Mazen Noureddin
Clin Mol Hepatol. 2023;29(2):394-397.   Published online April 1, 2023
View: 2366   Download: 79  Web of Science: 2
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
Clin Mol Hepatol. 2023;29(2):390-393.   Published online March 20, 2023
View: 2303   Download: 53  Web of Science: 2  Crossref: 2
Original Article
1430
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol. 2019;25(1):52-64.   Published online October 23, 2018
View: 8332   Download: 337  Web of Science: 73  Crossref: 70
Review
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol. 2017;23(2):103-108.   Published online May 10, 2017
View: 11909   Download: 472  Web of Science: 30  Crossref: 30
Original Article
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Seung Joo Kang, Min Jung Park, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee
Clin Mol Hepatol. 2012;18(4):383-390.   Published online December 21, 2012
View: 14463   Download: 119  Crossref: 81
5
Nonalcoholic Steatohepatitis
So-Young Jin
Clin Mol Hepatol. 2006;12(3):455-459.   Published online January 1, 2000
View: 2537   Download: 20
2
Insulin Resistance in Non-Alcoholic Fatty Liver Disease
Jeong Hyun Park
Clin Mol Hepatol. 2006;12(1):16-30.   Published online January 1, 1970
View: 2874   Download: 27
3
The Prevalence of Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease
Ki Won Moon, M.D., Joung Muk Leem, M.D., Sang Seok Bae, M.D., Ki Man Lee, M.D., Seok Hyung Kim, M.D.*, Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.
Clin Mol Hepatol. 2004;10(3):197-206.   Published online January 1, 1970
View: 3080   Download: 58
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1138
TOTAL : 1772094
Close layer